Infinium Pharmachem Board of Directors

Get the latest insights into the leadership at Infinium Pharmachem. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Sanjay Kumar PatelManaging Director
Pravin Bhada MadhaniNon Executive Director
Mitesh Lavji ChikhaliyaNon Executive Director
Keyur Jagdishchandra ShahNon Executive Independent Director
Vaishakhi ShuklaNon Executive Independent Director
Tarun Ratilal DobariyaNon Executive Independent Director
Nilesh PatelCompany Secretary & Compliance Officer, Chief Financial Officer

Infinium Pharmachem Share price

INFINIUM

210

0.95 (0.45%)
Last updated on 24 Apr, 2026 | 12:38 IST
Today's High

214.50

Today's Low

204.50

52 Week Low

189.40

52 Week High

337.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Infinium Pharmachem FAQs

The board at Infinium Pharmachem consists of experienced professionals, including Sanjay Kumar Patel, Pravin Bhada Madhani, and others, overseeing the company’s strategic and corporate governance.

Directors at Infinium Pharmachem are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Sanjay Kumar Patel is the current chairman at Infinium Pharmachem.

Executive directors at Infinium Pharmachem are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Infinium Pharmachem adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Infinium Pharmachem, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost